日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: The Combined Impact of Curcumin: Piperine and Sorafenib on microRNAs and Different Pathways in Breast Cancer Cells

更正:姜黄素、胡椒碱和索拉非尼联合作用对乳腺癌细胞中microRNA和不同通路的影响

Effat, Heba; Houseini, Motawa E El; Abohashem, Rehab S

The clinical potential of PDL-1 pathway and some related micro-RNAs as promising diagnostic markers for breast cancer.

PDL-1通路及一些相关microRNA作为乳腺癌有前景的诊断标志物的临床潜力

Al-Sharabass Eman A, El-Houseini Motawa E, Effat Heba, Ibrahim Sherif Abdelaziz, Abdellateif Mona S

Isatin, a monoamine oxidase inhibitor, sensitizes resistant breast cancer cells to tamoxifen via MAO-A/HIF1α/MMPs modulation.

靛红是一种单胺氧化酶抑制剂,它通过 MAO-A/HIF1α/MMPs 调节使耐药乳腺癌细胞对他莫昔芬敏感。

Abdelwahed Fatma M, Ibrahim Marwa A, Sharaky Marwa, Effat Heba

Effect of palliative radiotherapy and cyclin-dependent kinase 4/6 inhibitor on breast cancer cell lines

姑息性放疗和细胞周期蛋白依赖性激酶 4/6 抑制剂对乳腺癌细胞系的影响

Sharaky, Marwa; El Kiki, Shereen M; Effat, Heba; Mansour, Heba H

The Combined Impact of Curcumin: Piperine and Sorafenib on microRNAs and Different Pathways in Breast Cancer Cells.

姜黄素、胡椒碱和索拉非尼对乳腺癌细胞中microRNA和不同通路的影响

Effat Heba, El Houseini Motawa E, Abohashem Rehab S

Author Correction: Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel‑related ovarian damage in mice

作者更正:抑制Drp1可调控乳腺癌细胞对紫杉醇的反应性,但对小鼠紫杉醇相关的卵巢损伤的缓解作用甚微。

Alalawy, Adel I; Sakran, Mohamed; Alzuaibr, Fahad M; Alotaibi, Maeidh A; El-Hefnawy, Mohamed E; Hazazi, Abdulelah Y; El-Gendy, Saad M; Aidy, Esraa A; Effat, Heba; Ismail, Doha F; Hessien, Mohamed

Circulating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the Liver

循环 miR-210 和 miR-1246 作为区分肝细胞癌和肝转移瘤的潜在生物标志物

Ahmed, Emad K; Fahmy, Shaimaa A; Effat, Heba; Wahab, Abdel Hady Abdel